The FDA has approved lenacapavir, a groundbreaking antiviral drug for HIV prevention developed by biochemist Wesley Sundquist. Learn how this drug could change the future of HIV treatment and prevention.
In a surprising turn, the Trump administration has terminated key funding for HIV programs aimed at adolescents, raising concerns over the future of HIV prevention efforts in the U.S.
